Research

Mixed

Targeting mitochondrial dysfunction through dietary supplements (e.g., NAD+ precursors, antioxidants) and pharmacological agents shows promise in preclinical models but lacks robust clinical translation due to issues with stability and efficacy.

While specific mitochondrial supplements and drugs are being researched, current clinical evidence is limited. The most accessible way to support mitochondrial health remains regular physical activity, which promotes mitochondrial biogenesis and function, alongside a balanced diet that provides necessary nutrients for mitochondrial function.

ModerateQualifiesMEDIUM confidence
These small molecular drugs can either exert their effects directly on the mitochondria or influence the organelle indirectly by binding to their cytosolic or nuclear regulators. ... However, the clinical translation is still limited, including unstable mitochondrial vitality, inefficient cellular internalization, and transient therapeutic effects, which collectively hinder the medical practice.
Zong Yao et al. · Signal Transduction and Targeted Therapy · 2024

Why this rating

The paper is a review summarizing preclinical and limited clinical data; it does not present new primary clinical trial results.

Source

Mitochondrial dysfunction: mechanisms and advances in therapy

Zong Yao et al. · Signal Transduction and Targeted Therapy · 2024

DOI 10.1038/s41392-024-01839-8

narrative_reviewCited 945×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →